About prestige consumer healthcare inc. - PBH
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
PBH At a Glance
Prestige Consumer Healthcare, Inc.
660 White Plains Road
Tarrytown, New York 10591
| Phone | 1-914-524-6800 | Revenue | 1.09B | |
| Industry | Pharmaceuticals: Major | Net Income | 190.30M | |
| Sector | Health Technology | Employees | 890 | |
| Fiscal Year-end | 03 / 2027 | |||
| View SEC Filings |
PBH Valuation
| P/E Current | 14.469 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 15.174 |
| Price to Sales Ratio | 2.652 |
| Price to Book Ratio | 1.486 |
| Price to Cash Flow Ratio | 11.21 |
| Enterprise Value to EBITDA | 11.357 |
| Enterprise Value to Sales | 3.554 |
| Total Debt to Enterprise Value | 0.27 |
PBH Efficiency
| Revenue/Employee | 1,223,264.045 |
| Income Per Employee | 213,821.348 |
| Receivables Turnover | 5.673 |
| Total Asset Turnover | 0.311 |
PBH Liquidity
| Current Ratio | 3.568 |
| Quick Ratio | 2.252 |
| Cash Ratio | 0.528 |
PBH Profitability
| Gross Margin | 52.782 |
| Operating Margin | 28.42 |
| Pretax Margin | 23.652 |
| Net Margin | 17.48 |
| Return on Assets | 5.435 |
| Return on Equity | 10.225 |
| Return on Total Capital | 6.488 |
| Return on Invested Capital | 6.572 |
PBH Capital Structure
| Total Debt to Total Equity | 55.386 |
| Total Debt to Total Capital | 35.644 |
| Total Debt to Total Assets | 29.469 |
| Long-Term Debt to Equity | 54.721 |
| Long-Term Debt to Total Capital | 35.216 |
Prestige Consumer Healthcare Inc. in the News
Nearly 40,000 bottles of eye drops recalled nationwide over possible contamination
The voluntary recall was issued due to a "lack of assurance of sterility" in certain bottles of Clear Eyes Maximum Itchy Eye Relief sold nationwide.